Annual FCF
-$43.06 M
+$12.85 M+22.98%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual free cash flow is currently -$43.06 million, with the most recent change of +$12.85 million (+22.98%) on 31 December 2023. MLTX annual FCF is now at all-time high.MLTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$25.41 M
+$2.48 M+8.90%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly free cash flow is currently -$25.41 million, with the most recent change of +$2.48 million (+8.90%) on 30 September 2024. Over the past year, it has dropped by -$16.16 million (-174.65%). MLTX quarterly FCF is now -181.54% below its all-time high of -$9.02 million, reached on 31 March 2023.MLTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$80.80 M
-$16.16 M-24.99%
30 September 2024
Summary:
MoonLake Immunotherapeutics TTM free cash flow is currently -$80.80 million, with the most recent change of -$16.16 million (-24.99%) on 30 September 2024. Over the past year, it has dropped by -$38.77 million (-92.25%). MLTX TTM FCF is now -468.95% below its all-time high of -$14.20 million, reached on 31 March 2022.MLTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.0% | -174.7% | -92.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MLTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.0% | -181.5% | +8.9% | -468.9% | at low |
| 5 y | 5 years | at high | +23.0% | -181.5% | +8.9% | -468.9% | at low |
| alltime | all time | at high | +23.0% | -181.5% | +8.9% | -468.9% | at low |
MoonLake Immunotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.41 M(-8.9%) | -$80.80 M(+25.0%) |
| June 2024 | - | -$27.89 M(+84.0%) | -$64.65 M(+32.2%) |
| Mar 2024 | - | -$15.16 M(+22.8%) | -$48.91 M(+14.3%) |
| Dec 2023 | -$43.06 M | -$12.34 M(+33.4%) | -$42.78 M(+1.8%) |
| Sept 2023 | - | -$9.25 M(-23.9%) | -$42.03 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$12.16 M(+34.7%) | -$42.13 M(-17.0%) |
| Mar 2023 | - | -$9.02 M(-22.2%) | -$50.73 M(-9.3%) |
| Dec 2022 | -$55.91 M | -$11.60 M(+24.0%) | -$55.91 M(+26.2%) |
| Sept 2022 | - | -$9.35 M(-55.0%) | -$44.31 M(+26.7%) |
| June 2022 | - | -$20.76 M(+46.2%) | -$34.96 M(+146.2%) |
| Mar 2022 | - | -$14.20 M | -$14.20 M |
FAQ
- What is MoonLake Immunotherapeutics annual free cash flow?
- What is the all time high annual FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual FCF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
- What is MoonLake Immunotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
What is MoonLake Immunotherapeutics annual free cash flow?
The current annual FCF of MLTX is -$43.06 M
What is the all time high annual FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual free cash flow is -$43.06 M
What is MoonLake Immunotherapeutics annual FCF year-on-year change?
Over the past year, MLTX annual free cash flow has changed by +$12.85 M (+22.98%)
What is MoonLake Immunotherapeutics quarterly free cash flow?
The current quarterly FCF of MLTX is -$25.41 M
What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly free cash flow is -$9.02 M
What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
Over the past year, MLTX quarterly free cash flow has changed by -$16.16 M (-174.65%)
What is MoonLake Immunotherapeutics TTM free cash flow?
The current TTM FCF of MLTX is -$80.80 M
What is the all time high TTM FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM free cash flow is -$14.20 M
What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
Over the past year, MLTX TTM free cash flow has changed by -$38.77 M (-92.25%)